These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 21274301)

  • 1. Factors affecting IGF-I level and correlation with growth response during growth hormone treatment in LG Growth Study.
    Kim JH; Kim SJ; Lee J; Shin CH; Seo JY
    PLoS One; 2021; 16(7):e0252283. PubMed ID: 34280192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human growth hormone therapy - in three stages: past, present, and future.
    Hilczer M; Walczak M
    Pediatr Endocrinol Diabetes Metab; 2024; 30(2):49-50. PubMed ID: 39026480
    [No Abstract]   [Full Text] [Related]  

  • 3. Growth Hormone Dosing Estimations Based on Body Weight Versus Body Surface Area.
    Besci Ö; Deveci Sevim R; Yüksek Acinikli K; Akın Kağızmanlı G; Ersoy S; Demir K; Ünüvar T; Böber E; Anık A; Abacı A
    J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):268-275. PubMed ID: 36974729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Salivary IGF and IGF/IGFBP-3 Molar Ratio with Cervical Vertebral Maturation Stages from Pre-Adolescent to Post-Adolescent Transition Period-A Cross-Sectional Exploratory Study.
    Almalki A
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating whether serum IGF-1 and IGFBP-3 levels reflect the height outcome in prepubertal children upon rhGH therapy: LG growth study database.
    Kim M; Kim EY; Kim EY; So CH; Kim CJ
    PLoS One; 2021; 16(11):e0259287. PubMed ID: 34723984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF-I and IGFBP-3 assessment in the management of childhood onset growth hormone deficiency.
    Cianfarani S; Liguori A; Germani D
    Endocr Dev; 2005; 9():66-75. PubMed ID: 15879689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of renal failure on the growth hormone-insulin-like growth factor axis.
    Powell DR
    J Pediatr; 1997 Jul; 131(1 Pt 2):S13-6. PubMed ID: 9255220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined evaluation of IGF-1 and IGFBP-3 as an index of efficacy and safety in growth hormone treated patients.
    Sıklar Z; Öcal G; Berberoğlu M; Bilir P
    J Clin Res Pediatr Endocrinol; 2009; 1(5):240-3. PubMed ID: 21274301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 Molar Ratio Concentration and Height Outcome in Prepubertal Short Children on rhGH Treatment over Two Years of Therapy.
    Ballerini MG; Braslavsky D; Scaglia PA; Keselman A; Rodríguez ME; Martínez A; Freire AV; Domené HM; Jasper HG; Bergadá I; Ropelato MG
    Horm Res Paediatr; 2017; 88(5):354-363. PubMed ID: 28926833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone therapy does not alter the insulin-like growth factor-I/insulin-like growth factor binding protein-3 molar ratio in growth hormone-deficient children.
    Scirè G; Del Bianco C; Spadoni GL; Cianfarani S
    J Endocrinol Invest; 2008 Feb; 31(2):153-8. PubMed ID: 18362507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
    Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum IGF-I and IGFBP-3 levels of Turkish children during childhood and adolescence: establishment of reference ranges with emphasis on puberty.
    Bereket A; Turan S; Omar A; Berber M; Ozen A; Akbenlioglu C; Haklar G
    Horm Res; 2006; 65(2):96-105. PubMed ID: 16462144
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.